Previous 10 | Next 10 |
home / stock / tlt / tlt articles
It’s a day of risk aversion on Wall Street as investors are shedding both stocks and bonds in favor of cash while digesting the latest corpor...
Stocks enjoyed a positive midday trading session in New York, with all major indices in the green. Additionally, nine out of 11 S&P 500 sectors...
It’s a risk-on start to the week, with investors favoring riskier assets, buoyed by a significant drop in Treasury yields and a weakening U.S...
Thursday saw the U.S. stock market displaying mixed performance as 10-year Treasury yields approached the 5% threshold, only to recover in response...
Wall Street tumbled during midday trading, with all major stock indices in the red, and only the energy sector showing gains for the session, while...
Risk sentiment held steady on Tuesday as corporations continued to report better-than-expected earnings. Johnson & Johnson (NYSE:JNJ), Bank of ...
Wall Street started the week on a positive note, as all major U.S. indices and every sector within the S&P 500 showed gains during the morning ...
Risk aversion intensified during Friday’s morning trading, with stocks taking a sharp downturn while gold and oil rallied in the wake of heig...
Wall Street had a mixed morning session as investors carefully assessed the implications of another strong inflation report, pondering how it might...
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / July 8, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs ...
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...